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INTRODUCTION
Thoracic irradiation is often used in the
management of patients with cancer of the
breast, lung or eosophagus, Hodgkin's and non-
Hodgkin's lymphomas, and mediastinal
neoplasms. The lung is a dose limiting organ
and extent of radiation-induced pulmonary injury
depends on the irradiated volume, total dose,
fractionation and radiation energy applied
(Penney et ai, 1994; Roach III et ai, 1995).
There are three phases of lung response to
radiation: the early phase (latent period of
pneumonitis; first month), the intermediate
phase (acute pneumonitis; 1-6 months) and the
late phase (fibrosis; after 6 months) (Rubin and
Casseratt, 1968). Acute radiation pneumonitis, a
clinical syndrome including dyspnoe, cough,
fever and chest pain, occurs in 5 to 15% of
patients irradiated to the chest (Gross, 1977).
The unaffected pulmonary function is of
critical value and even its small reduction may
have clinical significance, particularly in patients
with long-term survival. Postradiation lung injury
may also have a considerable impact on
patient's quality of life. Avoiding of this sequelae
of radiation and its effective management is
therefore of particular importance.
Standard methods of detection and
grading of postradiation pulmonary toxicity have
until recently been based on clinical sign and
symptom scoring and on radiological evaluation
and have not taken into account functional
impairment. In consequence the lung injury
have in principle been assessed qualitatively.
Quantitative functional endpoints have only
recently been considered as a component of
staging system for Late Effects in Normal
Tissues (LENT) (Rubin et ai, 1995).
The aim of this article is to review the
methods of postradiation lung injury evaluation
with special reference to functional pulmonary
tests.
METHODS OF POSTRADIATION LUNG
INJURY ASSESSMENT
Signs and symptoms
Majority of radiation induced lung
injuries are asymptomatic. In relatively small
proportion of patients, however, dyspnoe,
Rep. Pract. Oncol. 1 (2) 1996
cough, fullnes in the chest and fever may occur,
usually 1-3 months after completion of radiation
therapy. Commonly the severity of dyspnoe is
scored according to the scale proposed by
Mahler (Mahler and Wells, 1988). Some
patients, particulary those with severe
pneumonitis, may develop symptoms of chronic
respiratory failure: exerted dyspnea, reduced
exercise tolerance, orthopnoe, cyanosis and,
occasionally, chronic cor pulmonale and finger
clubbing (Jassem et ai, in press).
Radiology
Chest radiography has traditionally been
used in evaluation of postradiation pulmonary
toxicity. The radiographic abnormalities appear
usually 2-3 months after completing
radiotherapy and include ground glass
opacification, diffuse alveolar or nodular
densities, and/or air bronchograms.
Occasionally pleural effusion is present (Gross,
1977). Radiation fibrosis usually develops within
the previously irradiated field 6-12 months after
radiotherapy, irrespective of whether or not the
acute syndrome was present earlier. Grading
systems to evaluate posttreatment fibrosis take
into account the intensity of radiological
changes and the involved area (Arriagada et
al,1989; Jensens et ai, 1985; Massilta et ai,
1991).
Recently computed tomography (CT)
has been advocated as the method of choice for
the radiological assessment of radiation induced
lung injUry. CT has been reported to
demonstrate radiation pneumonitis and fibrosis
at earlier stage and with greater sensitivity than
classical radiography (Nabawi et ai, 1981).
Libshitz et al. (Libshitz and Shuman, 1984)
proposed four different patterns of CT
abnormalities: 1. homogenous, slight increase in
density uniformly all over the irradiated area;
2. patchy consolidation within the area, but not
confined to the shape of irradiated area; 3.
discrete consolidation confined to the shape, but
not uniformly involving the irradiated area and 4.
solid consolidation confined to and totally
covering the irradiated area.
Experimental work of Shioya et at
(Shioya et ai, 1990) suggested the role of chest
magnetic resonance imaging (MRI) in early
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diagnosing of radiation pneumonitis. This
technique allows for detection of protein-rich
intraalveolar exudate or inflammatory cell
infiltrate. MRI may also be of value in
distinguishing radiation fibrosis from recurrent
tumor (Glazer et ai, 1985).
Other imaging technique for the
evaluation of radiation lung injury includes 111-
In Pentetreotide scanning (Valdes et ai, 1996).
The usefulness of this test in the diagnosis of
radiation-induced pulmonary changes has been
demonstrated in our own study (Jassem et ai, in
press).
Functional tests
One of the goals of classic pulmonary
function testing is to determine the type of
pulmonary defect in a particular patient.
Pulmonary radiation injuries are most frequently
of restrictive type with reductions of vital
capacity (VC), lung volumes and total lung
capacity (TLC). In the combined,
obstructive/restrictive type of injury, also forced
expiratory volume (FEV) is reduced. Moreover,
fibrosis may result in decreasing the airway
potency and lung compliance. Finally, there may
be an abnormal _gas transfer because of
alterations in the alveolar-capillary barrier.
Functional tests may evaluate either
local or overall lung function. The first group
includes nuclear medicine tests and the second
diffusion capacity assay (OLCO) and
spirometry.
Nuclear medicine tests
Planar ventilation and perfusion
scanning has long been used in assessing post-
radiation changes of the lung (Gross, 1977;
Prato et ai, 1977). Usually the decrease of
perfusion is larger than ventilation, thus leading
to an increase of ventilation/perfusion ratio
(Abratt and Willcox, 1995). The perfusion deficit
also seems to precede that of the ventilation.
This observation correlates with histological
findings showing early damage of the capillary
endothelium (Groth et ai, 1989). Recently, the
utility of single photon emission computed
tomography (SPECT) scans in the assessment
of post-radiation injuries has been reported
(Boersma et ai, 1995; Marks et ai, 1993).
Another useful test evaluating both
chemotherapy- and radiation-induced toxicity
includes 67-Gallium scanning of the lung. This
assay can additionally distinguish radiation
pneumonitis from pneumocistis carini
pneumopathy since the latter is heaVily labelled
with Gallium (Bisson et ai, 1983; Kataoka et ai,
1993).
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Diffusion capacity assay and spirometry
Some authors have stressed the
usefulness of diffusion capacity (OLCO)
measurement in evaluating pulmonary changes
(Abratt and Willcox, 1995, Mattson et ai, 1987).
DLCO has been demonstrated to be more
sensitive for detection of lung injury than
measurements of lung volumes (e.g. forced
expiratory volume in one second - FEV1) (Abratt
et ai, 1990). Decrease of OLCO is a result of
radiation damage at the capillary-alveolar level
(Law and Ahier, 1989), whereas the changes in
FEV1 are related to the balance between direct
tissue damage and the traction of adjacent
tissue follOWing fibrosis (Choi and Kanarek,
1994).
The role of functional tests
The possible role of functional pulmonary
assessment in patients irradiated to the chest
includes:
- prediction of lung injury
- diagnosis of lung injury and follow-up after
radiotherapy
- grading of lung injury
- monitoring of steroid therapy in patients with
symptomatic pneumonitis
Prediction of lung injury
Prediction of postradiation pUlmonary
function is a difficult and complex task. The
primary goal of these attempts is to maximize
the radiotherapy dose to the target volume while
minimizing normal tissue damage. The
predictive value of the individual functional tests
for post-therapy lung injury is a matter of
controversy (Abratt et ai, 1990; Choi, 1990). In
order to increase the predictive value of
pretherapy assessment, developed were tests
including a combination of functional assays. An
example of such an approach is coupling
quantitative radionuclide perfusion lung scans
with spirometry (an adaptation of the model
used by thoracic surgeons to estimate the ability
of lung cancer patients to tolerate a curative
resection) (Brady et ai, 1965; Bria et ai, 1983;
Rubenstein et ai, 1988). In this model
prospective prediction of the decline in lung
function after radiotherapy is calculated with the
use of the following formula:
post-treatment FEV1 = pre-treatment FEV1 x
(1-fraction of total lung perfusion in irradiated
field). .
The original study employing this
formula included 22 patients administered
postoperative or definitive radiotherapy for lung
cancer (Rubenstein et ai, 1988). The pulmonary
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impairment predicted with this method has only
rarely been exceeded. Two other studies by
Curran et al (Curran et ai, 1992) and Choi et al
(Choi and Kanarek, 1994) including 210 and
Table.1
Pulmonary function tests in prediction of lung injury
267 irradiated lung cancer patients, respectively,
demonstrated only limited predictive power of
used formula (table 1).
Author Malignancy No. of Tests Predictive value
pts
Choi (10) lung cancer 267 Quantitative perfusion and Uncertain
spirometry
Rubenstein (34) lung cancer 22 Quantitative perfusion and Uncertain
spirometry
Curran (12) lung cancer 210 Quantitative perfusion and Uncertain
spirometry
Boersma (6) lymphoma 25 Three-dimensional calculation Promising
Table 2.
Functional tests after completing radiotherapy
Author MaliQnancy No. DLCO* FEV1* VC* Qscan*
Boersma (5) lymphoma 24 19 18 20 10.5
MorQan (28) breast cancer 17 6 not done 7 not done
Groth (15) breast cancer 14 8 +5 4 NC
Mattson (27) lunQcancer 34 6 NC 1 NC
OLCO - diffusion capacity, FEV1 - forced expiratory flow for on second,
VC - vital capacity, Qscan - perfusion scanning, NC - no change
* % decrease from pretreatment value
In general, this technique tends to
overestimate the deletorious effect of irradiation.
Additionally, the second study demonstrated
that the predictive value of applied formula is
dependent on the level of pretreatment FEV1.
For values of FEV1 >70% the predictive power of
the test was acceptable, whereas for
FEV1 <50% the post-therapy FEV1 was
properly predicted in only 10% of patients.
Anyway, even with this imperfect method
aggressive thoracic irradiation in some patients
has been revised by altered arrangement of
radiotherapy fields.
An important problem in defining the
role of predictive tests in patients with lung
cancer given definitive radiotherapy is due to the
fact that the final pulmonary function is a result
of both: lung injury and improvement related to
decreased airflow obstruction following a tumor
response. The short survival period of these
patients has also added to the difficulties in
interpreting the data.
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Attempts have been made to correlate
the degree of lung injury with radiotherapeutic
factors, such as total and fraction dose,
fractionation schedule or irradiated volume
(Bornstein et ai, 1990; Martel et ai, 1994;
Mattson et ai, 1987). Recently adopted three-
-dimensional (3-D) planning systems enable
precise adjustement of the irradition portals to
the shape of target volume. Boersma et al.
(Boersma et ai, 1995) tried to develop a method
predicting the reduction of lung function and the
probability of developing radiation pneumonitis
based on 3-D dose distribution in the lung. In
this study the combination of 3-D dose
distribution with the average dose-effect relation
for local perfusion and' ventilation prior to
radiotherapy allowed for estimation of the
average relative reduction in local lung function.
This method also showed a good correlation
with the alterations of overall lung functions and
appeared to be related to the incidence and
severity of radiation pneumonitis (table 1).
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Diagnosis and follow-up
Most studies demonstrated no
significant alterations of spirometry tests (FEV1
and VG) immediately after completing
radiotherapy (Boersma et ai, 1995; Groth et ai,
1989; Mattson et al 1987; Morgan and Breit,
1995) (table 2). The deepest impairment has
been found for DLGO (Mattson et ai, 1987;
Morgan and Breit, 1995). At the time of
presentation of symptomatic radiation
pneumonitis generally decline in both diffusion
capacity and lung volumes was observed
(Jassem et ai, 1997; Mattson et al 1987). The
highest degree of deterioration, particulary in
OLGO, was usually observed after 3 months
(Boersma et al 1996; Jassem et ai, 1997;
Kaufman et ai, 1986). In our own material
including symptomatic patients, the lowest
average value for OLGO at this time was 56.4%
of predictive value, as compared with the initial
level of 72.7% (Jassem et ai, 1997). In the
report of Mattson et al. (Mattson et ai, 1987),
however, the highest decrease of OLGO (by
27%) was noted after 9 months. There are also
contradictory data on the spirometry and OLGO
pattern with longer follow-up (Boersma et ai,
1996; Smith et af, 1989). Boersma et al.
(Boersma et ai, 1996) observed a partial
recovery of local and basic overall lung function,
but not DLGO, between 3-4th and 18th month,
whereas Smith et al. (Smith et ai, 1989) found
no significant late impairment of pulmonary
function, including OLGO. In our own study
including 18 symptomatic radiation pneumonitis
patients all applied tests (OLGO, VG, FEV1 and
TLG) were worse after 12 months than at the
time of radiation pneumonitis diagnosis and
FEV1 was at that time the most impaired
function (Jassem et ai, 1997). Significant
decrease in FEV1 after 12 months (from 90.7%
to 77.2% of predictive value) in our series might
have been due to high incidence of severe
fibrosis in this highly selected patient population.
Grading of lung injury
As discussed earlier in this article, most
grading systems of pulmonary radiation injury
have been purely qualitative. The only exception
is recently published LENT system which
includes most of the functional tests addressed
in this paper. Other graded variables of the
LENT sytem are clinical symptoms and signs,
radiography and blood tests (Rubin et ai, 1995).
The value of this system still needs to be verified
in clinical setting.
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Monitoring of steroid therapy
Administration of corticosteroids is
considered a treatment of choice in symptomatic
disease. Therapy with these agents in most
instances results in a symptomatic relief, but
early dose reduction is frequently associated
with recurrence of symptoms. Although
symptomatic radiation pneumonitis is
experienced by only a small proportion of
patients given chest irradiation, the troublesome
course of this disease as well as the necessity
of prolonged corticosteroid therapy dictate the
need of better analysis of all concerned factors:
No prospective controlled trials on the
effectiveness of this therapy, its optimal duration
and dosage as well as on treatment monitoring
have been performed so far. In the retrospective
study including 18 symptomatic patients treated
with oral steroids, DLGO values usually
maximally decreased at the time of prednisone
dose reduction to the level of 15-20 mg (Jassem
et ai, in press). This alteration has frequently
been accompanied by an exacerbation of
clinical symptoms. A slight increase of
prednisone dose (5-10 mg) usually resulted in
symptomatic release and improvement of lung
function values. In some patients symptomatic
relief has also been achieved with the use of
inhaled steroids. The new promising agents
include long acting, high dose inhalation
compounds, e.g. fluticasene. Recently
pentoxiphillin has also been introduced in the
treatment of postradiation lung inju.ry
(Remiszewski and Roszkowski, 199~). The
experience with these forms of therapy have
until now been scarce and their role in
pulmonary damage warrants further studies. It
would be therefore of particular value to include
functional tests in evaluation of these novel
agents.
CONCLUSIONS
The wide range of functional tests
makes possible quantitative assessment of
postradiation lung injury. The available data,
however, do not yet allow recommendation of
any particular assay for the use in standard
care. Further evaluation of these methods,
including not only their efficacy but also cost
effectiveness and availability are warranted.
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